DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Tuberculosis Drug Market 2017-2021" report to their offering.
The analysts forecast the global tuberculosis drug market to grow at a CAGR of 3.17% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global tuberculosis drug market for 2017-2021. To calculate the market size, the report considers the volume and services.
Key vendors
- Lupin
- Otsuka Novel Products
- Pfizer
- Sandoz
- Sanofi
Other prominent vendors
- AstraZeneca
- Archivel Farma
- bioMérieux
- Cepheid
- EIKEN CHEMICAL
- Epistem
Market drivers
- Increase in outbreak of TB-HIV co-infections
- For a full, detailed list, view the full report
Market challenges
- Insufficient demand and high drug cost in developed countries
- For a full, detailed list, view the full report
Market trends
- Focus on development of shorter TB drug regimens
- For a full, detailed list, view the full report
For more information about this report visit http://www.researchandmarkets.com/research/w9m4c9/global
